Moleculin Biotech logo
Moleculin Biotech MBRX
€ 7.04 -5.15%
report update icon

Quartalsbericht 2026-Q3
hinzugefügt 13.11.2026

Moleculin Biotech Current Ratio | MBRX

Current Ratio Jährlich Moleculin Biotech

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
3.11 2.96 3.15 11 16.5 2.58 2.61 3.69 8.24 3.88 - - - - -

Alle Zahlen in USD-Währung

Indikatorenreichweite aus Jahresberichten

Höchstwert Mindestwert Durchschnitt
16.5 2.58 5.77

Current Ratio Vierteljährlich Moleculin Biotech

2026-Q3 2026-Q2 2026-Q1 2025-Q4 2025-Q3 2025-Q2 2025-Q1 2024-Q4 2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
3.32 2.22 2.86 3.11 0.43 0.86 2.91 2.96 1.47 3.25 3.33 3.15 9.01 6.88 9.49 11 9.4 10.6 12.8 16.5 11.9 10.6 8.86 2.58 2.14 1.99 2.5 2.61 2.66 3.26 3.22 3.69 3.52 3.29 5.72 8.24 10.4 10.7 4.87 11.4 13.2 15 11.4 0.04 0.04 0.04 0.04 - - - - - - - - - - - - - - - -

Alle Zahlen in USD-Währung

Indikatorspanne aus vierteljährlicher Berichterstattung

Höchstwert Mindestwert Durchschnitt
16.5 0.04 5.74

Current Ratio anderer Aktien in der Pharmaeinzelhändler

Name Current Ratio Preis % 24h Marktkapitalisierung Land
Annexon Annexon
ANNX
4.21 $ 3.11 -8.94 % $ 482 M usaUSA
Acasti Pharma Acasti Pharma
ACST
24.2 - 4.01 % $ 150 M canadaCanada
Aptose Biosciences Aptose Biosciences
APTO
0.269 - -45.71 % $ 1.2 M canadaCanada
Galapagos NV Galapagos NV
GLPG
20 - - $ 1.83 B belgiumBelgium
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
11.3 - -4.36 % $ 27 M usaUSA
Avenue Therapeutics Avenue Therapeutics
ATXI
2.67 - -52.27 % $ 4.45 M usaUSA
Galmed Pharmaceuticals Ltd. Galmed Pharmaceuticals Ltd.
GLMD
6.37 $ 4.63 21.05 % $ 20 M israelIsrael
Achieve Life Sciences Achieve Life Sciences
ACHV
2.06 $ 6.78 0.89 % $ 296 M usaUSA
Leap Therapeutics Leap Therapeutics
LPTX
16.9 - 368.57 % $ 41.9 M usaUSA
Lumos Pharma Lumos Pharma
LUMO
3.05 - - $ 35.3 M usaUSA
Gamida Cell Ltd. Gamida Cell Ltd.
GMDA
6.03 - -18.25 % $ 5.04 M israelIsrael
Axcella Health Axcella Health
AXLA
1.28 - -16.42 % $ 249 M usaUSA
Metacrine Metacrine
MTCR
6.97 - - $ 24.2 M usaUSA
Zealand Pharma A/S Zealand Pharma A/S
ZEAL
1.81 - 0.52 % $ 821 M danmarkDanmark
Myovant Sciences Ltd. Myovant Sciences Ltd.
MYOV
0.523 - -0.04 % $ 2.62 B usaUSA
Bellerophon Therapeutics Bellerophon Therapeutics
BLPH
1.47 - -74.18 % $ 955 K usaUSA
Idera Pharmaceuticals Idera Pharmaceuticals
IDRA
1.63 - -23.04 % $ 26.6 M usaUSA
Akero Therapeutics Akero Therapeutics
AKRO
10.9 - - $ 3.67 B usaUSA
Verona Pharma plc Verona Pharma plc
VRNA
1.76 - - $ 69.7 B britainBritain
Atreca Atreca
BCEL
2.02 - -11.76 % $ 5.79 M usaUSA
Guardion Health Sciences Guardion Health Sciences
GHSI
3.16 - -0.31 % $ 3.64 M usaUSA
Opiant Pharmaceuticals Opiant Pharmaceuticals
OPNT
2.99 - - $ 109 M usaUSA
Akouos Akouos
AKUS
6.18 - 0.23 % $ 488 M usaUSA
ImmunoGen ImmunoGen
IMGN
1.81 - - $ 7.92 B usaUSA
Vascular Biogenics Ltd. Vascular Biogenics Ltd.
VBLT
4.41 - -8.77 % $ 12.4 M israelIsrael
Cidara Therapeutics Cidara Therapeutics
CDTX
4.17 - - $ 1.41 B usaUSA
Iterum Therapeutics Iterum Therapeutics
ITRM
0.916 - - $ 591 K irlandaIrlanda
Virpax Pharmaceuticals Virpax Pharmaceuticals
VRPX
0.63 - -45.12 % $ 2.85 M usaUSA
Navidea Biopharmaceuticals Navidea Biopharmaceuticals
NAVB
0.349 - -2.99 % $ 2.47 M usaUSA
Stealth BioTherapeutics Corp Stealth BioTherapeutics Corp
MITO
0.526 - - $ 23.9 M usaUSA
OncoSec Medical Incorporated OncoSec Medical Incorporated
ONCS
1.39 - 31.87 % $ 1.61 M usaUSA
BioDelivery Sciences International BioDelivery Sciences International
BDSI
2.37 - -4.8 % $ 255 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
2.39 - -0.23 % $ 916 M usaUSA
bluebird bio bluebird bio
BLUE
0.936 - - $ 546 M usaUSA
Landos Biopharma Landos Biopharma
LABP
6.09 - 0.58 % $ 144 M usaUSA
CASI Pharmaceuticals CASI Pharmaceuticals
CASI
3.28 - - $ 35.4 M usaUSA
ContraFect Corporation ContraFect Corporation
CFRX
0.636 - -5.16 % $ 5.39 M usaUSA
Sigilon Therapeutics Sigilon Therapeutics
SGTX
1.81 - - $ 728 M usaUSA
Regulus Therapeutics Regulus Therapeutics
RGLS
10.8 - - $ 155 M usaUSA
NGM Biopharmaceuticals NGM Biopharmaceuticals
NGM
8.35 - - $ 127 M usaUSA
Aravive Aravive
ARAV
1.21 - -13.39 % $ 1.45 M usaUSA
Checkmate Pharmaceuticals Checkmate Pharmaceuticals
CMPI
8.41 - - $ 231 M usaUSA
Crinetics Pharmaceuticals Crinetics Pharmaceuticals
CRNX
8.39 $ 84.95 0.13 % $ 7.99 B usaUSA
Acer Therapeutics Acer Therapeutics
ACER
0.41 - 2.71 % $ 14 M usaUSA
Gilead Sciences Gilead Sciences
GILD
3.1 $ 166.01 -0.31 % $ 207 B usaUSA
Assembly Biosciences Assembly Biosciences
ASMB
5.07 $ 22.14 -1.6 % $ 248 M usaUSA
Dynavax Technologies Corporation Dynavax Technologies Corporation
DVAX
2.53 - - $ 2.02 B usaUSA
Turning Point Therapeutics Turning Point Therapeutics
TPTX
42.4 - -0.13 % $ 3.73 B usaUSA
Orgenesis Orgenesis
ORGS
0.0347 - -33.86 % $ 61.2 M usaUSA
TCR2 Therapeutics TCR2 Therapeutics
TCRR
3.09 - - $ 58.1 M usaUSA